

***

[(radiotherapy,may,may used,1.0), (radiotherapy,may,may used for tumour shrinkage,1.0), (tumour,remains following,systemic therapy,1.0), (radiotherapy,may,may used for tumour shrinkage prior,1.0), (primary tumour,remains following,therapy,1.0), (radiotherapy,may,may used for tumour shrinkage prior to surgery,1.0), (tumour,remains following,therapy,1.0), (primary tumour,remains,unresectable,1.0), (primary tumour,remains following,systemic therapy,1.0), (tumour,remains,unresectable,1.0)][(radiotherapy,may,may used,1.0), (radiotherapy,may,may used for tumour shrinkage,1.0), (tumour,remains following,systemic therapy,1.0), (radiotherapy,may,may used for tumour shrinkage prior,1.0), (primary tumour,remains following,therapy,1.0), (radiotherapy,may,may used for tumour shrinkage prior to surgery,1.0), (tumour,remains following,therapy,1.0), (primary tumour,remains,unresectable,1.0), (primary tumour,remains following,systemic therapy,1.0), (tumour,remains,unresectable,1.0)][(radiotherapy,may,may used,1.0), (radiotherapy,may,may used for tumour shrinkage,1.0), (tumour,remains following,systemic therapy,1.0), (radiotherapy,may,may used for tumour shrinkage prior,1.0), (primary tumour,remains following,therapy,1.0), (radiotherapy,may,may used for tumour shrinkage prior to surgery,1.0), (tumour,remains following,therapy,1.0), (primary tumour,remains,unresectable,1.0), (primary tumour,remains following,systemic therapy,1.0), (tumour,remains,unresectable,1.0)][(radiotherapy,may,may used,1.0), (radiotherapy,may,may used for tumour shrinkage,1.0), (tumour,remains following,systemic therapy,1.0), (radiotherapy,may,may used for tumour shrinkage prior,1.0), (primary tumour,remains following,therapy,1.0), (radiotherapy,may,may used for tumour shrinkage prior to surgery,1.0), (tumour,remains following,therapy,1.0), (primary tumour,remains,unresectable,1.0), (primary tumour,remains following,systemic therapy,1.0), (tumour,remains,unresectable,1.0)][(radiotherapy,may,may used,1.0), (radiotherapy,may,may used for tumour shrinkage,1.0), (tumour,remains following,systemic therapy,1.0), (radiotherapy,may,may used for tumour shrinkage prior,1.0), (primary tumour,remains following,therapy,1.0), (radiotherapy,may,may used for tumour shrinkage prior to surgery,1.0), (tumour,remains following,therapy,1.0), (primary tumour,remains,unresectable,1.0), (primary tumour,remains following,systemic therapy,1.0), (tumour,remains,unresectable,1.0)][(radiotherapy,may,may used,1.0), (radiotherapy,may,may used for tumour shrinkage,1.0), (tumour,remains following,systemic therapy,1.0), (radiotherapy,may,may used for tumour shrinkage prior,1.0), (primary tumour,remains following,therapy,1.0), (radiotherapy,may,may used for tumour shrinkage prior to surgery,1.0), (tumour,remains following,therapy,1.0), (primary tumour,remains,unresectable,1.0), (primary tumour,remains following,systemic therapy,1.0), (tumour,remains,unresectable,1.0)][(radiotherapy,may,may used,1.0), (radiotherapy,may,may used for tumour shrinkage,1.0), (tumour,remains following,systemic therapy,1.0), (radiotherapy,may,may used for tumour shrinkage prior,1.0), (primary tumour,remains following,therapy,1.0), (radiotherapy,may,may used for tumour shrinkage prior to surgery,1.0), (tumour,remains following,therapy,1.0), (primary tumour,remains,unresectable,1.0), (primary tumour,remains following,systemic therapy,1.0), (tumour,remains,unresectable,1.0)][(radiotherapy,may,may used,1.0), (radiotherapy,may,may used for tumour shrinkage,1.0), (tumour,remains following,systemic therapy,1.0), (radiotherapy,may,may used for tumour shrinkage prior,1.0), (primary tumour,remains following,therapy,1.0), (radiotherapy,may,may used for tumour shrinkage prior to surgery,1.0), (tumour,remains following,therapy,1.0), (primary tumour,remains,unresectable,1.0), (primary tumour,remains following,systemic therapy,1.0), (tumour,remains,unresectable,1.0)][(radiotherapy,may,may used,1.0), (radiotherapy,may,may used for tumour shrinkage,1.0), (tumour,remains following,systemic therapy,1.0), (radiotherapy,may,may used for tumour shrinkage prior,1.0), (primary tumour,remains following,therapy,1.0), (radiotherapy,may,may used for tumour shrinkage prior to surgery,1.0), (tumour,remains following,therapy,1.0), (primary tumour,remains,unresectable,1.0), (primary tumour,remains following,systemic therapy,1.0), (tumour,remains,unresectable,1.0)][(radiotherapy,may,may used,1.0), (radiotherapy,may,may used for tumour shrinkage,1.0), (tumour,remains following,systemic therapy,1.0), (radiotherapy,may,may used for tumour shrinkage prior,1.0), (primary tumour,remains following,therapy,1.0), (radiotherapy,may,may used for tumour shrinkage prior to surgery,1.0), (tumour,remains following,therapy,1.0), (primary tumour,remains,unresectable,1.0), (primary tumour,remains following,systemic therapy,1.0), (tumour,remains,unresectable,1.0)]

***

[(disease,is,present,1.0), (radiotherapy,is,reserved,1.0), (metastatic disease,is,When present,1.0), (radiotherapy,is generally reserved for,management of symptoms,1.0), (locoregional radiotherapy,is,generally reserved,1.0), (radiotherapy,is reserved for,management of tumour-related symptoms,1.0), (radiotherapy,is reserved for,management,1.0), (locoregional radiotherapy,is reserved for,management of tumour-related symptoms,1.0), (locoregional radiotherapy,is,reserved,1.0), (radiotherapy,is generally reserved for,management,1.0), (radiotherapy,is,generally reserved,1.0), (radiotherapy,is reserved for,management of symptoms,1.0), (locoregional radiotherapy,is reserved for,management,1.0), (disease,is,When present,1.0), (locoregional radiotherapy,is reserved for,management of symptoms,1.0), (locoregional radiotherapy,is generally reserved for,management of symptoms,1.0), (metastatic disease,is,present,1.0), (locoregional radiotherapy,is generally reserved for,management,1.0), (locoregional radiotherapy,is generally reserved for,management of tumour-related symptoms,1.0), (radiotherapy,is generally reserved for,management of tumour-related symptoms,1.0)][(disease,is,present,1.0), (radiotherapy,is,reserved,1.0), (metastatic disease,is,When present,1.0), (radiotherapy,is generally reserved for,management of symptoms,1.0), (locoregional radiotherapy,is,generally reserved,1.0), (radiotherapy,is reserved for,management of tumour-related symptoms,1.0), (radiotherapy,is reserved for,management,1.0), (locoregional radiotherapy,is reserved for,management of tumour-related symptoms,1.0), (locoregional radiotherapy,is,reserved,1.0), (radiotherapy,is generally reserved for,management,1.0), (radiotherapy,is,generally reserved,1.0), (radiotherapy,is reserved for,management of symptoms,1.0), (locoregional radiotherapy,is reserved for,management,1.0), (disease,is,When present,1.0), (locoregional radiotherapy,is reserved for,management of symptoms,1.0), (locoregional radiotherapy,is generally reserved for,management of symptoms,1.0), (metastatic disease,is,present,1.0), (locoregional radiotherapy,is generally reserved for,management,1.0), (locoregional radiotherapy,is generally reserved for,management of tumour-related symptoms,1.0), (radiotherapy,is generally reserved for,management of tumour-related symptoms,1.0)][(disease,is,present,1.0), (radiotherapy,is,reserved,1.0), (metastatic disease,is,When present,1.0), (radiotherapy,is generally reserved for,management of symptoms,1.0), (locoregional radiotherapy,is,generally reserved,1.0), (radiotherapy,is reserved for,management of tumour-related symptoms,1.0), (radiotherapy,is reserved for,management,1.0), (locoregional radiotherapy,is reserved for,management of tumour-related symptoms,1.0), (locoregional radiotherapy,is,reserved,1.0), (radiotherapy,is generally reserved for,management,1.0), (radiotherapy,is,generally reserved,1.0), (radiotherapy,is reserved for,management of symptoms,1.0), (locoregional radiotherapy,is reserved for,management,1.0), (disease,is,When present,1.0), (locoregional radiotherapy,is reserved for,management of symptoms,1.0), (locoregional radiotherapy,is generally reserved for,management of symptoms,1.0), (metastatic disease,is,present,1.0), (locoregional radiotherapy,is generally reserved for,management,1.0), (locoregional radiotherapy,is generally reserved for,management of tumour-related symptoms,1.0), (radiotherapy,is generally reserved for,management of tumour-related symptoms,1.0)][(disease,is,present,1.0), (radiotherapy,is,reserved,1.0), (metastatic disease,is,When present,1.0), (radiotherapy,is generally reserved for,management of symptoms,1.0), (locoregional radiotherapy,is,generally reserved,1.0), (radiotherapy,is reserved for,management of tumour-related symptoms,1.0), (radiotherapy,is reserved for,management,1.0), (locoregional radiotherapy,is reserved for,management of tumour-related symptoms,1.0), (locoregional radiotherapy,is,reserved,1.0), (radiotherapy,is generally reserved for,management,1.0), (radiotherapy,is,generally reserved,1.0), (radiotherapy,is reserved for,management of symptoms,1.0), (locoregional radiotherapy,is reserved for,management,1.0), (disease,is,When present,1.0), (locoregional radiotherapy,is reserved for,management of symptoms,1.0), (locoregional radiotherapy,is generally reserved for,management of symptoms,1.0), (metastatic disease,is,present,1.0), (locoregional radiotherapy,is generally reserved for,management,1.0), (locoregional radiotherapy,is generally reserved for,management of tumour-related symptoms,1.0), (radiotherapy,is generally reserved for,management of tumour-related symptoms,1.0)][(disease,is,present,1.0), (radiotherapy,is,reserved,1.0), (metastatic disease,is,When present,1.0), (radiotherapy,is generally reserved for,management of symptoms,1.0), (locoregional radiotherapy,is,generally reserved,1.0), (radiotherapy,is reserved for,management of tumour-related symptoms,1.0), (radiotherapy,is reserved for,management,1.0), (locoregional radiotherapy,is reserved for,management of tumour-related symptoms,1.0), (locoregional radiotherapy,is,reserved,1.0), (radiotherapy,is generally reserved for,management,1.0), (radiotherapy,is,generally reserved,1.0), (radiotherapy,is reserved for,management of symptoms,1.0), (locoregional radiotherapy,is reserved for,management,1.0), (disease,is,When present,1.0), (locoregional radiotherapy,is reserved for,management of symptoms,1.0), (locoregional radiotherapy,is generally reserved for,management of symptoms,1.0), (metastatic disease,is,present,1.0), (locoregional radiotherapy,is generally reserved for,management,1.0), (locoregional radiotherapy,is generally reserved for,management of tumour-related symptoms,1.0), (radiotherapy,is generally reserved for,management of tumour-related symptoms,1.0)][(disease,is,present,1.0), (radiotherapy,is,reserved,1.0), (metastatic disease,is,When present,1.0), (radiotherapy,is generally reserved for,management of symptoms,1.0), (locoregional radiotherapy,is,generally reserved,1.0), (radiotherapy,is reserved for,management of tumour-related symptoms,1.0), (radiotherapy,is reserved for,management,1.0), (locoregional radiotherapy,is reserved for,management of tumour-related symptoms,1.0), (locoregional radiotherapy,is,reserved,1.0), (radiotherapy,is generally reserved for,management,1.0), (radiotherapy,is,generally reserved,1.0), (radiotherapy,is reserved for,management of symptoms,1.0), (locoregional radiotherapy,is reserved for,management,1.0), (disease,is,When present,1.0), (locoregional radiotherapy,is reserved for,management of symptoms,1.0), (locoregional radiotherapy,is generally reserved for,management of symptoms,1.0), (metastatic disease,is,present,1.0), (locoregional radiotherapy,is generally reserved for,management,1.0), (locoregional radiotherapy,is generally reserved for,management of tumour-related symptoms,1.0), (radiotherapy,is generally reserved for,management of tumour-related symptoms,1.0)][(disease,is,present,1.0), (radiotherapy,is,reserved,1.0), (metastatic disease,is,When present,1.0), (radiotherapy,is generally reserved for,management of symptoms,1.0), (locoregional radiotherapy,is,generally reserved,1.0), (radiotherapy,is reserved for,management of tumour-related symptoms,1.0), (radiotherapy,is reserved for,management,1.0), (locoregional radiotherapy,is reserved for,management of tumour-related symptoms,1.0), (locoregional radiotherapy,is,reserved,1.0), (radiotherapy,is generally reserved for,management,1.0), (radiotherapy,is,generally reserved,1.0), (radiotherapy,is reserved for,management of symptoms,1.0), (locoregional radiotherapy,is reserved for,management,1.0), (disease,is,When present,1.0), (locoregional radiotherapy,is reserved for,management of symptoms,1.0), (locoregional radiotherapy,is generally reserved for,management of symptoms,1.0), (metastatic disease,is,present,1.0), (locoregional radiotherapy,is generally reserved for,management,1.0), (locoregional radiotherapy,is generally reserved for,management of tumour-related symptoms,1.0), (radiotherapy,is generally reserved for,management of tumour-related symptoms,1.0)][(disease,is,present,1.0), (radiotherapy,is,reserved,1.0), (metastatic disease,is,When present,1.0), (radiotherapy,is generally reserved for,management of symptoms,1.0), (locoregional radiotherapy,is,generally reserved,1.0), (radiotherapy,is reserved for,management of tumour-related symptoms,1.0), (radiotherapy,is reserved for,management,1.0), (locoregional radiotherapy,is reserved for,management of tumour-related symptoms,1.0), (locoregional radiotherapy,is,reserved,1.0), (radiotherapy,is generally reserved for,management,1.0), (radiotherapy,is,generally reserved,1.0), (radiotherapy,is reserved for,management of symptoms,1.0), (locoregional radiotherapy,is reserved for,management,1.0), (disease,is,When present,1.0), (locoregional radiotherapy,is reserved for,management of symptoms,1.0), (locoregional radiotherapy,is generally reserved for,management of symptoms,1.0), (metastatic disease,is,present,1.0), (locoregional radiotherapy,is generally reserved for,management,1.0), (locoregional radiotherapy,is generally reserved for,management of tumour-related symptoms,1.0), (radiotherapy,is generally reserved for,management of tumour-related symptoms,1.0)][(disease,is,present,1.0), (radiotherapy,is,reserved,1.0), (metastatic disease,is,When present,1.0), (radiotherapy,is generally reserved for,management of symptoms,1.0), (locoregional radiotherapy,is,generally reserved,1.0), (radiotherapy,is reserved for,management of tumour-related symptoms,1.0), (radiotherapy,is reserved for,management,1.0), (locoregional radiotherapy,is reserved for,management of tumour-related symptoms,1.0), (locoregional radiotherapy,is,reserved,1.0), (radiotherapy,is generally reserved for,management,1.0), (radiotherapy,is,generally reserved,1.0), (radiotherapy,is reserved for,management of symptoms,1.0), (locoregional radiotherapy,is reserved for,management,1.0), (disease,is,When present,1.0), (locoregional radiotherapy,is reserved for,management of symptoms,1.0), (locoregional radiotherapy,is generally reserved for,management of symptoms,1.0), (metastatic disease,is,present,1.0), (locoregional radiotherapy,is generally reserved for,management,1.0), (locoregional radiotherapy,is generally reserved for,management of tumour-related symptoms,1.0), (radiotherapy,is generally reserved for,management of tumour-related symptoms,1.0)][(disease,is,present,1.0), (radiotherapy,is,reserved,1.0), (metastatic disease,is,When present,1.0), (radiotherapy,is generally reserved for,management of symptoms,1.0), (locoregional radiotherapy,is,generally reserved,1.0), (radiotherapy,is reserved for,management of tumour-related symptoms,1.0), (radiotherapy,is reserved for,management,1.0), (locoregional radiotherapy,is reserved for,management of tumour-related symptoms,1.0), (locoregional radiotherapy,is,reserved,1.0), (radiotherapy,is generally reserved for,management,1.0), (radiotherapy,is,generally reserved,1.0), (radiotherapy,is reserved for,management of symptoms,1.0), (locoregional radiotherapy,is reserved for,management,1.0), (disease,is,When present,1.0), (locoregional radiotherapy,is reserved for,management of symptoms,1.0), (locoregional radiotherapy,is generally reserved for,management of symptoms,1.0), (metastatic disease,is,present,1.0), (locoregional radiotherapy,is generally reserved for,management,1.0), (locoregional radiotherapy,is generally reserved for,management of tumour-related symptoms,1.0), (radiotherapy,is generally reserved for,management of tumour-related symptoms,1.0)][(disease,is,present,1.0), (radiotherapy,is,reserved,1.0), (metastatic disease,is,When present,1.0), (radiotherapy,is generally reserved for,management of symptoms,1.0), (locoregional radiotherapy,is,generally reserved,1.0), (radiotherapy,is reserved for,management of tumour-related symptoms,1.0), (radiotherapy,is reserved for,management,1.0), (locoregional radiotherapy,is reserved for,management of tumour-related symptoms,1.0), (locoregional radiotherapy,is,reserved,1.0), (radiotherapy,is generally reserved for,management,1.0), (radiotherapy,is,generally reserved,1.0), (radiotherapy,is reserved for,management of symptoms,1.0), (locoregional radiotherapy,is reserved for,management,1.0), (disease,is,When present,1.0), (locoregional radiotherapy,is reserved for,management of symptoms,1.0), (locoregional radiotherapy,is generally reserved for,management of symptoms,1.0), (metastatic disease,is,present,1.0), (locoregional radiotherapy,is generally reserved for,management,1.0), (locoregional radiotherapy,is generally reserved for,management of tumour-related symptoms,1.0), (radiotherapy,is generally reserved for,management of tumour-related symptoms,1.0)][(disease,is,present,1.0), (radiotherapy,is,reserved,1.0), (metastatic disease,is,When present,1.0), (radiotherapy,is generally reserved for,management of symptoms,1.0), (locoregional radiotherapy,is,generally reserved,1.0), (radiotherapy,is reserved for,management of tumour-related symptoms,1.0), (radiotherapy,is reserved for,management,1.0), (locoregional radiotherapy,is reserved for,management of tumour-related symptoms,1.0), (locoregional radiotherapy,is,reserved,1.0), (radiotherapy,is generally reserved for,management,1.0), (radiotherapy,is,generally reserved,1.0), (radiotherapy,is reserved for,management of symptoms,1.0), (locoregional radiotherapy,is reserved for,management,1.0), (disease,is,When present,1.0), (locoregional radiotherapy,is reserved for,management of symptoms,1.0), (locoregional radiotherapy,is generally reserved for,management of symptoms,1.0), (metastatic disease,is,present,1.0), (locoregional radiotherapy,is generally reserved for,management,1.0), (locoregional radiotherapy,is generally reserved for,management of tumour-related symptoms,1.0), (radiotherapy,is generally reserved for,management of tumour-related symptoms,1.0)][(disease,is,present,1.0), (radiotherapy,is,reserved,1.0), (metastatic disease,is,When present,1.0), (radiotherapy,is generally reserved for,management of symptoms,1.0), (locoregional radiotherapy,is,generally reserved,1.0), (radiotherapy,is reserved for,management of tumour-related symptoms,1.0), (radiotherapy,is reserved for,management,1.0), (locoregional radiotherapy,is reserved for,management of tumour-related symptoms,1.0), (locoregional radiotherapy,is,reserved,1.0), (radiotherapy,is generally reserved for,management,1.0), (radiotherapy,is,generally reserved,1.0), (radiotherapy,is reserved for,management of symptoms,1.0), (locoregional radiotherapy,is reserved for,management,1.0), (disease,is,When present,1.0), (locoregional radiotherapy,is reserved for,management of symptoms,1.0), (locoregional radiotherapy,is generally reserved for,management of symptoms,1.0), (metastatic disease,is,present,1.0), (locoregional radiotherapy,is generally reserved for,management,1.0), (locoregional radiotherapy,is generally reserved for,management of tumour-related symptoms,1.0), (radiotherapy,is generally reserved for,management of tumour-related symptoms,1.0)][(disease,is,present,1.0), (radiotherapy,is,reserved,1.0), (metastatic disease,is,When present,1.0), (radiotherapy,is generally reserved for,management of symptoms,1.0), (locoregional radiotherapy,is,generally reserved,1.0), (radiotherapy,is reserved for,management of tumour-related symptoms,1.0), (radiotherapy,is reserved for,management,1.0), (locoregional radiotherapy,is reserved for,management of tumour-related symptoms,1.0), (locoregional radiotherapy,is,reserved,1.0), (radiotherapy,is generally reserved for,management,1.0), (radiotherapy,is,generally reserved,1.0), (radiotherapy,is reserved for,management of symptoms,1.0), (locoregional radiotherapy,is reserved for,management,1.0), (disease,is,When present,1.0), (locoregional radiotherapy,is reserved for,management of symptoms,1.0), (locoregional radiotherapy,is generally reserved for,management of symptoms,1.0), (metastatic disease,is,present,1.0), (locoregional radiotherapy,is generally reserved for,management,1.0), (locoregional radiotherapy,is generally reserved for,management of tumour-related symptoms,1.0), (radiotherapy,is generally reserved for,management of tumour-related symptoms,1.0)][(disease,is,present,1.0), (radiotherapy,is,reserved,1.0), (metastatic disease,is,When present,1.0), (radiotherapy,is generally reserved for,management of symptoms,1.0), (locoregional radiotherapy,is,generally reserved,1.0), (radiotherapy,is reserved for,management of tumour-related symptoms,1.0), (radiotherapy,is reserved for,management,1.0), (locoregional radiotherapy,is reserved for,management of tumour-related symptoms,1.0), (locoregional radiotherapy,is,reserved,1.0), (radiotherapy,is generally reserved for,management,1.0), (radiotherapy,is,generally reserved,1.0), (radiotherapy,is reserved for,management of symptoms,1.0), (locoregional radiotherapy,is reserved for,management,1.0), (disease,is,When present,1.0), (locoregional radiotherapy,is reserved for,management of symptoms,1.0), (locoregional radiotherapy,is generally reserved for,management of symptoms,1.0), (metastatic disease,is,present,1.0), (locoregional radiotherapy,is generally reserved for,management,1.0), (locoregional radiotherapy,is generally reserved for,management of tumour-related symptoms,1.0), (radiotherapy,is generally reserved for,management of tumour-related symptoms,1.0)][(disease,is,present,1.0), (radiotherapy,is,reserved,1.0), (metastatic disease,is,When present,1.0), (radiotherapy,is generally reserved for,management of symptoms,1.0), (locoregional radiotherapy,is,generally reserved,1.0), (radiotherapy,is reserved for,management of tumour-related symptoms,1.0), (radiotherapy,is reserved for,management,1.0), (locoregional radiotherapy,is reserved for,management of tumour-related symptoms,1.0), (locoregional radiotherapy,is,reserved,1.0), (radiotherapy,is generally reserved for,management,1.0), (radiotherapy,is,generally reserved,1.0), (radiotherapy,is reserved for,management of symptoms,1.0), (locoregional radiotherapy,is reserved for,management,1.0), (disease,is,When present,1.0), (locoregional radiotherapy,is reserved for,management of symptoms,1.0), (locoregional radiotherapy,is generally reserved for,management of symptoms,1.0), (metastatic disease,is,present,1.0), (locoregional radiotherapy,is generally reserved for,management,1.0), (locoregional radiotherapy,is generally reserved for,management of tumour-related symptoms,1.0), (radiotherapy,is generally reserved for,management of tumour-related symptoms,1.0)][(disease,is,present,1.0), (radiotherapy,is,reserved,1.0), (metastatic disease,is,When present,1.0), (radiotherapy,is generally reserved for,management of symptoms,1.0), (locoregional radiotherapy,is,generally reserved,1.0), (radiotherapy,is reserved for,management of tumour-related symptoms,1.0), (radiotherapy,is reserved for,management,1.0), (locoregional radiotherapy,is reserved for,management of tumour-related symptoms,1.0), (locoregional radiotherapy,is,reserved,1.0), (radiotherapy,is generally reserved for,management,1.0), (radiotherapy,is,generally reserved,1.0), (radiotherapy,is reserved for,management of symptoms,1.0), (locoregional radiotherapy,is reserved for,management,1.0), (disease,is,When present,1.0), (locoregional radiotherapy,is reserved for,management of symptoms,1.0), (locoregional radiotherapy,is generally reserved for,management of symptoms,1.0), (metastatic disease,is,present,1.0), (locoregional radiotherapy,is generally reserved for,management,1.0), (locoregional radiotherapy,is generally reserved for,management of tumour-related symptoms,1.0), (radiotherapy,is generally reserved for,management of tumour-related symptoms,1.0)][(disease,is,present,1.0), (radiotherapy,is,reserved,1.0), (metastatic disease,is,When present,1.0), (radiotherapy,is generally reserved for,management of symptoms,1.0), (locoregional radiotherapy,is,generally reserved,1.0), (radiotherapy,is reserved for,management of tumour-related symptoms,1.0), (radiotherapy,is reserved for,management,1.0), (locoregional radiotherapy,is reserved for,management of tumour-related symptoms,1.0), (locoregional radiotherapy,is,reserved,1.0), (radiotherapy,is generally reserved for,management,1.0), (radiotherapy,is,generally reserved,1.0), (radiotherapy,is reserved for,management of symptoms,1.0), (locoregional radiotherapy,is reserved for,management,1.0), (disease,is,When present,1.0), (locoregional radiotherapy,is reserved for,management of symptoms,1.0), (locoregional radiotherapy,is generally reserved for,management of symptoms,1.0), (metastatic disease,is,present,1.0), (locoregional radiotherapy,is generally reserved for,management,1.0), (locoregional radiotherapy,is generally reserved for,management of tumour-related symptoms,1.0), (radiotherapy,is generally reserved for,management of tumour-related symptoms,1.0)][(disease,is,present,1.0), (radiotherapy,is,reserved,1.0), (metastatic disease,is,When present,1.0), (radiotherapy,is generally reserved for,management of symptoms,1.0), (locoregional radiotherapy,is,generally reserved,1.0), (radiotherapy,is reserved for,management of tumour-related symptoms,1.0), (radiotherapy,is reserved for,management,1.0), (locoregional radiotherapy,is reserved for,management of tumour-related symptoms,1.0), (locoregional radiotherapy,is,reserved,1.0), (radiotherapy,is generally reserved for,management,1.0), (radiotherapy,is,generally reserved,1.0), (radiotherapy,is reserved for,management of symptoms,1.0), (locoregional radiotherapy,is reserved for,management,1.0), (disease,is,When present,1.0), (locoregional radiotherapy,is reserved for,management of symptoms,1.0), (locoregional radiotherapy,is generally reserved for,management of symptoms,1.0), (metastatic disease,is,present,1.0), (locoregional radiotherapy,is generally reserved for,management,1.0), (locoregional radiotherapy,is generally reserved for,management of tumour-related symptoms,1.0), (radiotherapy,is generally reserved for,management of tumour-related symptoms,1.0)][(disease,is,present,1.0), (radiotherapy,is,reserved,1.0), (metastatic disease,is,When present,1.0), (radiotherapy,is generally reserved for,management of symptoms,1.0), (locoregional radiotherapy,is,generally reserved,1.0), (radiotherapy,is reserved for,management of tumour-related symptoms,1.0), (radiotherapy,is reserved for,management,1.0), (locoregional radiotherapy,is reserved for,management of tumour-related symptoms,1.0), (locoregional radiotherapy,is,reserved,1.0), (radiotherapy,is generally reserved for,management,1.0), (radiotherapy,is,generally reserved,1.0), (radiotherapy,is reserved for,management of symptoms,1.0), (locoregional radiotherapy,is reserved for,management,1.0), (disease,is,When present,1.0), (locoregional radiotherapy,is reserved for,management of symptoms,1.0), (locoregional radiotherapy,is generally reserved for,management of symptoms,1.0), (metastatic disease,is,present,1.0), (locoregional radiotherapy,is generally reserved for,management,1.0), (locoregional radiotherapy,is generally reserved for,management of tumour-related symptoms,1.0), (radiotherapy,is generally reserved for,management of tumour-related symptoms,1.0)]

***

[(We,reviewed,our experience,1.0), (We,reviewed,our experience of high-dose radiotherapy,1.0), (We,reviewed,our experience of radiotherapy,1.0)][(We,reviewed,our experience,1.0), (We,reviewed,our experience of high-dose radiotherapy,1.0), (We,reviewed,our experience of radiotherapy,1.0)][(We,reviewed,our experience,1.0), (We,reviewed,our experience of high-dose radiotherapy,1.0), (We,reviewed,our experience of radiotherapy,1.0)]